Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 2,137–2,144 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Inhibikase Therapeutics Inc. IkT-001Pro Blood and Gastrointestinal Cancers NDA Filing Type Meeting Oral Oncology
Inhibrx Biosciences Inc. INBRX-106 with Keytruda (pembrolizumab) Locally advanced unresectable or metastatic head and neck squamous cell carcinoma (HNSCC) Phase 2/3 Ongoing Intravenous Oncology
InMed Pharmaceuticals Inc. INM-755 Epidermolysis Bullosa Phase 2 Data Released Topical Genetic Disorder
INmune Bio Inc. Quellor Immune mediated complications from COVID-19 Phase 2 Trial Discontinued Intramuscular injection COVID-19
INmune Bio Inc. LIVNate Nonalcoholic steatohepatitis (NASH) Phase 2 Trial Planned Oral Gastroenterology
INmune Bio Inc. XPro (XPro1595) Treatment resistant depression Phase 2 Hold Removed Subcutaneous Psychiatric
INmune Bio Inc. XPro1595 (pegipanermin) - (XPro) Neuroinflammation caused by Alzheimer’s disease Phase 2 Ongoing Subcutaneous Neurology
INmune Bio Inc. XPRO1595 - (MINDFuL) Early Alzheimer's Disease (AD) Phase 2 Data Released Subcutaneous Neurology
1…266267268269270…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.